"10.1371_journal.pone.0138622","plos one","2015-09-25T00:00:00Z","Eveline J Langereis; Tom Wagemans; Wim Kulik; Dirk J Lefeber; Henk van Lenthe; Esmee Oussoren; Ans T van der Ploeg; George J Ruijter; Ron A Wevers; Frits A Wijburg; Naomi van Vlies","Department of Pediatric Metabolic Diseases, Emma Children’s Hospital and Amsterdam Lysosome Center ‘Sphinx’, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; Laboratory for Genetic Metabolic Diseases, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; Translational Metabolic Laboratory, Departments of Neurology & Laboratory Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands; Department of Pediatrics, Center for Lysosomal and Metabolic Diseases, Erasmus Medical Center, Rotterdam, The Netherlands; Department of Clinical Genetics, Center for Lysosomal and Metabolic Diseases, Erasmus Medical Center, Rotterdam, The Netherlands","Conceived and designed the experiments: EJL FAW NVV. Performed the experiments: TW HVL WK NVV. Analyzed the data: EJL. Contributed reagents/materials/analysis tools: DJL EO ATVDP GJR RAW FAW. Wrote the paper: EJL FAW NVV.","Biomarin pharmaceutical inc financially supported development of the assay. Furthermore, this does not alter adherence to PLOS ONE policies on sharing data and materials. The authors have declared that no competing interests exist.","2015","09","Eveline J Langereis","EJL",11,FALSE,3,4,1,3,TRUE,TRUE,FALSE,0,NA,FALSE
